These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7577614)

  • 1. Bcl6/Laz3 rearrangements in post-transplant lymphoproliferative disorders.
    Delecluse HJ; Rouault JP; Jeammot B; Kremmer E; Bastard C; Berger F
    Br J Haematol; 1995 Sep; 91(1):101-3. PubMed ID: 7577614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
    Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
    Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.
    Cesarman E; Chadburn A; Liu YF; Migliazza A; Dalla-Favera R; Knowles DM
    Blood; 1998 Oct; 92(7):2294-302. PubMed ID: 9746767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in situ hybridization identifies new chromosomal changes involving 3q27 in non-Hodgkin's lymphomas with BCL6/LAZ3 rearrangement.
    Wlodarska I; Mecucci C; Stul M; Michaux L; Pittaluga S; Hernandez JM; Cassiman JJ; De Wolf-Peeters C; Van den Berghe H
    Genes Chromosomes Cancer; 1995 Sep; 14(1):1-7. PubMed ID: 8527378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation.
    Bernardin F; Collyn-d'Hooghe M; Quief S; Bastard C; Leprince D; Kerckaert JP
    Oncogene; 1997 Feb; 14(7):849-55. PubMed ID: 9047392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular genetics of post-transplantation lymphoproliferative disorders.
    Knowles DM
    Springer Semin Immunopathol; 1998; 20(3-4):357-73. PubMed ID: 9870251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.
    Capello D; Berra E; Cerri M; Gaidano G
    Minerva Med; 2004 Feb; 95(1):53-64. PubMed ID: 15041926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease.
    McKnight JL; Cen H; Riddler SA; Breinig MC; Williams PA; Ho M; Joseph PS
    Leuk Lymphoma; 1994 Sep; 15(1-2):9-16. PubMed ID: 7858507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.
    Nalesnik MA; Starzl TE
    Transplant Sci; 1994 Sep; 4(1):61-79. PubMed ID: 7804700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous implantation of human post-transplant lymphoproliferative disease lesions in SCID mice.
    Randhawa PS; Pietrzak B; Nalesnik MA; Demetris AJ; Locker J
    Hematol Oncol; 1997 Feb; 15(1):39-46. PubMed ID: 9378472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
    Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
    Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
    Smir BN; Hauke RJ; Bierman PJ; Gross TG; d'Amore F; Anderson JR; Greiner TC
    Lab Invest; 1996 Oct; 75(4):575-88. PubMed ID: 8874388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transplant lymphoproliferative disorders with genetic abnormalities commonly found in malignant tumours.
    Delecluse HJ; Rouault JP; Ffrench M; Dureau G; Magaud JP; Berger F
    Br J Haematol; 1995 Jan; 89(1):90-7. PubMed ID: 7833283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBV-induced post-transplant lymphoproliferative disorder (PTLD).
    Birkeland SA; Hamilton-Dutoit S; Sandvej K; Andersen HM; Bendtzen K; Møller B; Jørgensen KA
    Transplant Proc; 1995 Dec; 27(6):3467-72. PubMed ID: 8540055
    [No Abstract]   [Full Text] [Related]  

  • 15. Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms: comparison with lymphomas associated with BCL2 rearrangement.
    Muramatsu M; Akasaka T; Kadowaki N; Ohno H; Yamabe H; Edamura S; Dor S; Mori T; Okuma M; Fukuhara S
    Br J Haematol; 1996 Jun; 93(4):911-20. PubMed ID: 8703825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of the LAZ3 (BCL6) proto-oncogene accompanies murine skeletal myogenesis.
    Albagli-Curiel O; Dhordain P; Lantoine D; Auradé F; Quief S; Kerckaert JP; Montarras D; Pinset C
    Differentiation; 1998 Nov; 64(1):33-44. PubMed ID: 9921651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease.
    Montone KT; Hodinka RL; Salhany KE; Lavi E; Rostami A; Tomaszewski JE
    Mod Pathol; 1996 Jun; 9(6):621-30. PubMed ID: 8782198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo.
    Dhordain P; Albagli O; Ansieau S; Koken MH; Deweindt C; Quief S; Lantoine D; Leutz A; Kerckaert JP; Leprince D
    Oncogene; 1995 Dec; 11(12):2689-97. PubMed ID: 8545127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?
    Leblond V; Davi F; Charlotte F; Dorent R; Bitker MO; Sutton L; Gandjbakhch I; Binet JL; Raphael M
    J Clin Oncol; 1998 Jun; 16(6):2052-9. PubMed ID: 9626203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus induced lymphoproliferative tumors in severe combined immunodeficient mice are oligoclonal.
    Pisa P; Cannon MJ; Pisa EK; Cooper NR; Fox RI
    Blood; 1992 Jan; 79(1):173-9. PubMed ID: 1309425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.